Most cited papers in Gallbladder and Bile Duct Disorders
What are the most cited papers in Gallbladder and Bile Duct Disorders?
The most cited paper in Gallbladder and Bile Duct Disorders is "Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer" (Juan W. Valle, Harpreet Singh Wasan, Daniel H. Palmer et al., 2010), with 4,489 citations. Next come "The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After" (4,323) and "Postoperative pancreatic fistula: An international study group (ISGPF) definition" (4,297).
Showing 50 of 100 papers. Every paper with more than 730 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer Juan W. Valle, Harpreet Singh Wasan, Daniel H. Palmer et al. · New England Journal of Medicine | 7 Apr 2010 | 4,489 |
| 2 | The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After Claudio Bassi et al. · Surgery | 28 Dec 2016 | 4,323 |
| 3 | Postoperative pancreatic fistula: An international study group (ISGPF) definition Claudio Bassi, Christos Dervenis, Giovanni Butturini et al. · Surgery | Jul 2005 | 4,297 |
| 4 | Endoscopic sphincterotomy complications and their management: an attempt at consensus Peter B. Cotton, Glen A. Lehman, Jack A. Vennes et al. · Gastrointestinal Endoscopy | May 1991 | 2,873 |
| 5 | Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definition Moritz N. Wente, Johannes A. Veit, Claudio Bassi et al. · Surgery | Jul 2007 | 2,637 |
| 6 | Complications of Endoscopic Biliary Sphincterotomy Martin L. Freeman, Douglas B. Nelson, Stuart Sherman et al. · New England Journal of Medicine | 26 Sep 1996 | 2,570 |
| 7 | A lexicon for endoscopic adverse events: report of an ASGE workshop Peter B. Cotton, Glenn M. Eisen, Lars Aabakken et al. · Gastrointestinal Endoscopy | 27 Feb 2010 | 2,504 |
| 8 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Masao Tanaka, Carlos Fernández-del Castillo, Volkan N. Adsay et al. · Pancreatology | May 2012 | 2,359 |
| 9 | Practice Guidelines in Acute Pancreatitis Peter A. Banks, Martin L. Freeman · The American Journal of Gastroenterology | Oct 2006 | 2,082 |
| 10 | Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery Moritz Koch et al. · Surgery | 15 Feb 2011 | 2,011 |
| 11 | Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas Masao Tanaka, Carlos Fernández‐del Castillo, Terumi Kamisawa et al. · Pancreatology | 13 Jul 2017 | 1,816 |
| 12 | Histochemistry of Hepatic Phosphatases at a Physiologic pH: With Special Reference to the Demonstration of Bile Canaliculi M. Wachstein, Elizabeth Meisel · American Journal of Clinical Pathology | 1957 | 1,813 |
| 13 | Cholangiocarcinoma Nataliya Razumilava, Gregory J Gores · The Lancet | 26 Feb 2014 | 1,805 |
| 14 | Pancreatitis and the Risk of Pancreatic Cancer Albert B. Lowenfels, Patrick Maisonneuve, Giorgio Cavallini et al. · New England Journal of Medicine | 20 May 1993 | 1,760 |
| 15 | Proposed classification of complications of surgery with examples of utility in cholecystectomy. Pierre-Alain Clavien, Juan Ramon Sanabria, Steven M. Strasberg · PubMed | May 1992 | 1,640 |
| 16 | Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma John A. Bridgewater, Peter R. Galle, Shahid Ahmed Khan et al. · Journal of Hepatology | 27 Mar 2014 | 1,570 |
| 17 | Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos) Masamichi Yokoe et al. · Journal of Hepato-Biliary-Pancreatic Sciences | 15 Oct 2017 | 1,544 |
| 18 | EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis Gideon Morris Hirschfield, Ulrich H. Beuers, Christophe Corpechot et al. · Journal of Hepatology | 18 Apr 2017 | 1,500 |
| 19 | Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) Jesús M. Bañales et al. · Nature Reviews Gastroenterology & Hepatology | 20 Apr 2016 | 1,429 |
| 20 | Complications of laparoscopic cholecystectomy: A national survey of 4,292 hospitals and an analysis of 77,604 cases Daniel J. Deziel, Keith W. Millikan, Steven G. Economou et al. · The American Journal of Surgery | 1993 | 1,397 |
| 21 | Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer Laura M. Stinton, Eldon A. Shaffer · Gut and Liver | 15 Apr 2012 | 1,396 |
| 22 | Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study William Robert Brugge, Kent B Lewandrowski, Elizabeth Lee-Lewandrowski et al. · Gastroenterology | May 2004 | 1,386 |
| 23 | Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma William R. Jarnagin, Yuman Fong, Ronald P. DeMatteo et al. · Annals of Surgery | Oct 2001 | 1,371 |
| 24 | Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Marc G. Besselink et al. · The Lancet | Feb 2008 | 1,366 |
| 25 | Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma Sumera Irie Ilyas, Gregory James Gores · Gastroenterology | 15 Oct 2013 | 1,363 |
| 26 | Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity Anthony Nicholas Kalloo, Vikesh K. Singh, Sanjay B. Jagannath et al. · Gastrointestinal Endoscopy | Jul 2004 | 1,333 |
| 27 | Cholangiocarcinoma Michelle Lucinda DeOliveira, Steven Clark Cunningham, John L. Cameron et al. · Annals of Surgery | 20 Apr 2007 | 1,311 |
| 28 | A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after Pancreatoduodenectomy Mark P. Callery, Wande B. Pratt, Tara Sotsky Kent et al. · Journal of the American College of Surgeons | Nov 2012 | 1,276 |
| 29 | Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study John N Primrose et al. · The Lancet Oncology | 26 Mar 2019 | 1,273 |
| 30 | Risk factors for post-ERCP pancreatitis: A prospective, multicenter study Martin L. Freeman, James A. DiSario, Douglas B. Nelson et al. · Gastrointestinal Endoscopy | Oct 2001 | 1,261 |
| 31 | Diagnosis and Management of Primary Sclerosing Cholangitis Roger William Chapman, Johan Fevery, Anthony Nicholas Kalloo et al. · Hepatology | 9 Sep 2009 | 1,231 |
| 32 | Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies Angelo Andriulli, Silvano Loperfido, Grazia Napolitano et al. · The American Journal of Gastroenterology | 18 May 2007 | 1,206 |
| 33 | Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer Do‐Youn Oh et al. · NEJM Evidence | Jun 2022 | 1,205 |
| 34 | Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study Silvano Loperfido, Giampaolo Angelini, Giorgio Benedetti et al. · Gastrointestinal Endoscopy | Jul 1998 | 1,195 |
| 35 | Cholangiocarcinoma Attila Nakeeb, Henry Anthony Pitt, Taylor A. Sohn et al. · Annals of Surgery | Oct 1996 | 1,186 |
| 36 | International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding Alan N. Barkun, Marc Bardou, Ernst J. Kuipers et al. · Annals of Internal Medicine | 19 Jan 2010 | 1,164 |
| 37 | Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Robin Kate Kelley et al. · The Lancet | 16 Apr 2023 | 1,150 |
| 38 | The Epidemiology of Cholangiocarcinoma Yasser H. Shaib, Hashem B. El‐Serag · Seminars in Liver Disease | 11 Jun 2004 | 1,147 |
| 39 | A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis Frederik Nevens et al. · New England Journal of Medicine | 17 Aug 2016 | 1,137 |
| 40 | Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy Yizhou Wang, Jun Li, Yong Xia et al. · Journal of Clinical Oncology | 28 Jan 2013 | 1,129 |
| 41 | Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Mikio MAKUUCHI, Bao Le Thai, Kentaro Takayasu et al. · PubMed | May 1990 | 1,123 |
| 42 | The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) Paul Singh Sidhu et al. · Ultraschall in der Medizin - European Journal of Ultrasound | 6 Mar 2018 | 1,100 |
| 43 | Biliary tract cancer Juan W. Valle, Robin Katie Kelley, Bruno Nervi et al. · The Lancet | 2021 | 1,076 |
| 44 | Gallbladder cancer: epidemiology and outcome Eldon A. Shaffer, Rajveer Hundal · Clinical Epidemiology | Mar 2014 | 1,076 |
| 45 | The physicochemical basis of cholesterol gallstone formation in man William H. Admirand, DONALD M. SMALL · Journal of Clinical Investigation | May 1968 | 1,069 |
| 46 | Cholangiocarcinoma Shahid Ahmed Khan, Howard C. Thomas, Brian Ritchie Davidson et al. · The Lancet | Oct 2005 | 1,061 |
| 47 | Preoperative Biliary Drainage for Cancer of the Head of the Pancreas Niels Anthony Van Der Gaag, Erik A. Rauws, Casper H.J. van Eijck et al. · New England Journal of Medicine | 13 Jan 2010 | 1,049 |
| 48 | Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction Paul H. P. Davids, A.K. Groen, E. A. J. Rauws et al. · The Lancet | Dec 1992 | 1,014 |
| 49 | Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States Tushar P Patel · Hepatology | Jun 2001 | 1,011 |
| 50 | Risk factors for cholangiocarcinoma Gia L. Tyson, Hashem B. El‐Serag · Hepatology | 12 Apr 2011 | 979 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.